The company provides independently operated facilities with comprehensive technology, support, and back-office services. In 2025, 36 of PACS's post-acute communities were recognized on U.S. News & World Report's Best Nursing Homes list, spanning multiple states including California, South Carolina, Nevada, Colorado, Missouri, and Texas.
Cyborg Score Rationale
The company faces significant headwinds from securities fraud class action lawsuits and Medicare fraud allegations filed in late 2024. PACS completed a restatement reducing revenue by $14.9M for Q1 2024 and $46.1M for Q2 2024, and an Audit Committee investigation into a short-seller report concluded in November 2025. However, recent analyst ratings and revenue growth show recovery momentum.
Top Insights
Revenue grew 31.44% year-over-year in 2024 to $4.09 billion, demonstrating strong operational scaling.
Full-year 2025 guidance projects revenue of $5.25B–$5.35B and Adjusted EBITDA of $480M–$490M.
According to 3 analysts, the average rating for PACS stock is 'Strong Buy'.
As of late 2025, the company operates 321 facilities across 17 states following recent acquisitions.
Named Competitors
Senior Care Industries — Senior living communities with assisted living and skilled nursing
Sunrise Senior Living — Premium assisted living and memory care services
Skilled Nursing Operations — Healthcare real estate investment and operator
Recent Developments
(January 2026) Acquired three post-acute care facilities in Alaska and Idaho.
(November 2025) Completed restatement, Audit Committee investigation, and became current with SEC filings.
(November 2025) Released full-year 2025 guidance for $5.25B–$5.35B revenue and $480M–$490M Adjusted EBITDA.
Open the full interactive PACS Group, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.